Lenalidomide

FDA Approved: * August 31, 2022
Pharm Company: * LOTUS PHARM CO LTD
Category: Cancer

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS).[2] For multiple myeloma, it is used after at least one other treatment and generally with dexamethasone.[2] It is taken by mouth.[2] Common side effects include diarrhea, itchiness, joint pain, fever, headache, and trouble sleeping.[2] Severe side effects include l... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Lenalidomide 2.5 mg Oral Capsule
NDC: 0378-1935
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 5 mg Oral Capsule
NDC: 0378-1936
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 10 mg Oral Capsule
NDC: 0378-1937
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 25 mg Oral Capsule
NDC: 0378-1940
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 15 mg Oral Capsule
NDC: 0378-1941
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 20 mg Oral Capsule
NDC: 0378-1942
Labeler:
Mylan Pharmaceuticals Inc.
Lenalidomide 2.5 mg Oral Capsule
NDC: 0480-1241
Labeler:
Teva Pharmaceuticals, Inc.
Lenalidomide 5 mg Oral Capsule
NDC: 0480-1242
Labeler:
Teva Pharmaceuticals, Inc.
Lenalidomide 10 mg Oral Capsule
NDC: 0480-1243
Labeler:
Teva Pharmaceuticals, Inc.
Lenalidomide 15 mg Oral Capsule
NDC: 0480-1244
Labeler:
Teva Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients